0001040368-20-000001.txt : 20200526 0001040368-20-000001.hdr.sgml : 20200526 20200526113148 ACCESSION NUMBER: 0001040368-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200526 DATE AS OF CHANGE: 20200526 EFFECTIVENESS DATE: 20200526 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Advanced Proteome Therapeutics CORP CENTRAL INDEX KEY: 0001040368 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-367643 FILM NUMBER: 20908684 BUSINESS ADDRESS: STREET 1: BIOSQUARE, 650 ALBANY STREET STREET 2: SUITE 113 CITY: BOSTON STATE: MA ZIP: 02118 BUSINESS PHONE: 617-638-0340 MAIL ADDRESS: STREET 1: BIOSQUARE, 650 ALBANY STREET STREET 2: SUITE 113 CITY: BOSTON STATE: MA ZIP: 02118 FORMER COMPANY: FORMER CONFORMED NAME: THRILLTIME ENTERTAINMENT INTERNATIONAL INC DATE OF NAME CHANGE: 19970903 FORMER COMPANY: FORMER CONFORMED NAME: NEWERA CAPITAL CORP DATE OF NAME CHANGE: 19970603 D 1 primary_doc.xml X0708 D LIVE 0001040368 Advanced Proteome Therapeutics CORP 104-8337 Eastlake Drive Burnaby A1 BRITISH COLUMBIA, CANADA V5A 4W2 6048978025 BRITISH COLUMBIA, CANADA Advanced Proteome Therapeutics (Canada) Inc. THRILLTIME ENTERTAINMENT INTERNATIONAL INC NEWERA CAPITAL CORP Corporation true Paul Woodward 804-750 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 2T7 Executive Officer Director President and CEO Martin Woodward 804-750 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 2T7 Executive Officer Director Secretary Ken Phillippe 804-750 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 2T7 Executive Officer CFO Ben Catalano 804-750 West Pender Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 2T7 Director Biotechnology No Revenues 06b false 2020-05-19 false true true true true Each unit consists of 1 common share and 1 transferable share purchase warrant. Each warrant is exercisable at a price of CAD$0.10 per share for 2 years. false 0 342286 127151 215135 The additional USD$215,135 may be received upon the exercise of warrants sold inside and outside the U.S. US dollar amounts are based on the Bank of Canada noon rate of exchange on May 19/20, CAD$1.3898 = US$1; and May 22/20, CAD$1.4015 = USD$1. false 3 0 0 0 false Advanced Proteome Therapeutics CORP /s/ Paul Woodward Paul Woodward President and CEO 2020-05-26